Cardiopulmonary bypass changes the plasma proteome in children undergoing tetralogy of Fallot repair

Perfusion. 2015 Oct;30(7):556-64. doi: 10.1177/0267659114566065. Epub 2015 Jan 6.

Abstract

Introduction: Cardiopulmonary bypass (CPB) can be associated with deleterious clinical effects. However, the impact of CPB on inflammatory, immunological and other homeostatic pathways remains poorly understood. We investigated the impact of CPB on the plasma proteome in children undergoing tetralogy of Fallot repair.

Methods: Blood samples were taken from 20 children prior to and at the end of CPB and 6h, 12h and 24h after CPB. Plasma was analysed by liquid chromatography-mass spectrometry (LC-MS) in a label-free, untargeted approach. Data were analysed using Genedata software to identify peptides that were differentially expressed (p<0.01 above a false discovery rate). Proteins were identified from peptides that demonstrated differential expression.

Results: The proteins that were found to be differentially expressed were haptoglobin isoform 1 preproprotein, isoform 2 of semaphorin-6C, vitamin D-binding protein, inter-alpha-trypsin inhibitor, ceruloplasmin, apolipoprotein B100 and fibrinogen alpha.

Conclusion: CPB alters the plasma proteome with differences most apparent at 6h and 12h post CPB. There was a return to baseline with no proteins differentially regulated by 24h.

Keywords: cardiac surgery; cardiopulmonary bypass; mass spectrometry; paediatric; proteins; proteomics.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiopulmonary Bypass*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Proteome / metabolism*
  • Tetralogy of Fallot / blood*
  • Tetralogy of Fallot / surgery*

Substances

  • Proteome